REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Radical -xh Acid, Or Anhydride, Acid Halide Or Salt Thereof (x Is Chalcogen) Doai > Carboxylic Acid, Percarboxylic Acid, Or Salt Thereof (e.g., Peracetic Acid, Etc.) > Benzene Ring Nonionically Bonded > Polycyclo Ring System Polycyclo Ring SystemPolycyclo Ring System patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.02/01/07 - 20070027217 - Composition and method for preventing secondary burn ischemia A cream composition for the topical application of ibuprofen to prevent secondary burn ischemia, inducing changes in the dynamics of blood flow in the region of application. The cream composition includes approximately 0.5 g of 1% ibuprofen cream. A single application of ibuprofen cream to the surface of a skin ... 01/25/07 - 20070021508 - Method for treatment of helicobacter pylori infection and/or an associated disease in which R1 and R2, independently, are C1-C8alkyl or H, R3 is aryl or heteroaryl, and n is 0, 1, 2, 3, 4, 5 or 6. The present invention also relates to a method for treatment of Helicobacter pylori (HP) infection or disease associated with HP infection by administering a ... 11/02/06 - 20060247316 - Food supplement A food supplement having prophylactic and cancer effects, wherein the supplement comprises 20 to 99% by weight of a product of biosynthesis by the productive microorganism Penicillium oxalicum var. Armeniaca CCM 8242, obtained by fermentation of a nutrient broth containing carbohydrates and ammonia nitrogen, and 0.01 to 8% by weight ... 10/19/06 - 20060235080 - Treatment or prevention of cancer and precancerous disorders The NSAID, sulindac and/or its metabolites and derivatives, in combination with hydrogen peroxide or another oxidizing agent, such as arsenic trioxide that generates reactive oxygen species (ROS), significantly enhances the killing of cancer cells. This effect occurs at concentrations of each compound that individually have little or no activity directed ... 06/15/06 - 20060128809 - Rapidly absorbed liquid compositions The present invention provides a method which provides for a faster absorption of pharmaceutically acceptable amines. The method provides a pharmaceutically acceptable amine in combination with a non-steroidal anti-inflammatory drug in a liquid form. A preferred embodiment employs pseudoephedrine and ibuprofen. ... 06/15/06 - 20060128808 - Method of using adapalene in acne maintenance therapy The present invention provides for a method of using adapalene for the maintenance theray of acne vulgaris to prevent acne recurrence or reduce the severity of the acne recurrence. ... 06/01/06 - 20060116427 - Adapalene polymorphic forms Novel adapalene crystalline and amorphous Forms, processes for the preparation thereof, their use for the purification of adapalene, pharmaceutical compositions containing the forms and the use thereof in therapy. ... 03/16/06 - 20060058392 - Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase The invention concerns a novel therapeutic application of rhein and diacerhein. Rhein and diacerhein, as well as the salts and esters thereof, can be used for treating diseases requiring a rise in the rate of the heme oxygenase enzyme, providing prevention and inhibition of stress on cells and tissues, and ... 03/02/06 - 20060047003 - Fullerene compositions for ameliorating hearing loss, collateral damage of chemotherapy, or mucositis This patent discloses a method of ameliorating a hearing loss, collateral damage of chemotherapy, or mucositis in a mammal, comprising administering a composition comprising a substituted fullerene to the mammal afflicted with the hearing loss, collateral damage of chemotherapy, or mucositis or potentially afflicted with the hearing loss, collateral damage ... 01/26/06 - 20060020037 - Tazarotenic acid and esters thereof for treating autism This invention provides a method of treating autism comprising administering a therapeutically effective amount of a compound selected from the group consisting of tazarotenic acid, or ester or salt, thereof, to a person in need of such treatment. Preferably said compound is tazarotene. ... 12/29/05 - 20050288375 - Method and composition for treating neurodegenerative disorders The invention provides compositions and methods for treating neurodegenerative disorders. A method of the invention involves administering to an individual in need of treatment a composition having an R-NSAID and an NMDA antagonist. Another method of the invention involves administering to an individual in need of treatment a composition having ... 10/27/05 - 20050239897 - Mesenchymal stem cells and uses therefor Methods of treating autoimmune diseases, allergic responses, cancer, or inflammatory diseases in an animal, promoting would healing, and promoting angiogenesis in an organ or tissue of an animal by administering to the animal mesenchymal stem cells in an effective amount. ... 09/22/05 - 20050209335 - Methods for use of targretin in organ transplant rejection, autoimmune diseases and cancer Methods are provided for treatment of graft versus host disease and other autoimmune diseases, organ transplant rejection, acute myeloid leukemia and T-cell non-Hodgkin's lymphoma other than cutaneous T-cell lymphoma in patients by administration of TARGRETIN. Also provided are methods for increasing neutrophil count and boosting the immune system of patients ... 08/25/05 - 20050187298 - Methods for treating retinoid responsive disorders using selective inhibitors of cyp26a and cyp26b The invention provides methods for treating an individual having a retinoid responsive disorder. In one embodiment, a method involves administering to the individual an effective amount of a selective CYP26B inhibitor, the selective CYP26B inhibitor having at least 10-fold selectivity for CYP26B relative to CYP26A. In another embodiment, a method ... 08/04/05 - 20050171205 - Process for the preparation of substituted 2-(phenoxymethyl) benzoic acids b) the compound (IV) formed as intermediate in step a) is reacted in the presence of a base B2 with a compound (V) to give the compound of the general formula (I) ... 06/23/05 - 20050137262 - Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses Concentrated pourable potassium ibuprofen liquid compositions and their preparation are described. They are comprised of (i) potassium ibuprofen, (ii) water; and (iii) methanol, ethanol, 1-propanol, 2-propanol, 1,1-dimethylethanol, or a mixture of any two or more of them. The amount of dissolved potassium ibuprofen in the composition is in the range ... 06/23/05 - 20050137261 - Method for treating inflammatory bowel diseases The present invention relates to a method for treating an inflammatory bowel disease, including administering an effective amount of 1,4-dihydroxy-2-naphthoic acid or a salt thereof. ... 06/09/05 - 20050124697 - Nsaid-containing topical formulations that demonstrate chemopreventive activity Disclosed herein are chemopreventive methods and topical formulations for the prevention and treatment of ultraviolet light-induced skin cancers, pre-cancerous lesions, and hyperproliferative disorders in mammals, such as humans, utilizing doses of non-steroidal anti-inflammatory drugs. Low doses of non-steroidal anti-inflammatory drugs are present in the topical formulations and allow continued regular ... ### FreshPatents.com Support |